Article Versions Notes

Zheng YF, Bae SH, Huang Z, Chae SU, Jo SJ, Shim HJ, Lee CB, Kim D, Yoo H, Bae SK. Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone. Pharmaceutics. 2020; 12(4):328. https://doi.org/10.3390/pharmaceutics12040328

Zheng, Yu Fen, Soo Hyeon Bae, Zhouchi Huang, Soon Uk Chae, Seong Jun Jo, Hyung Joon Shim, Chae Bin Lee, Doyun Kim, Hunseung Yoo, and Soo Kyung Bae. 2020. "Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone" Pharmaceutics 12, no. 4: 328. https://doi.org/10.3390/pharmaceutics12040328

Zheng, Y. F., Bae, S. H., Huang, Z., Chae, S. U., Jo, S. J., Shim, H. J., Lee, C. B., Kim, D., Yoo, H., & Bae, S. K. (2020). Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone. Pharmaceutics, 12(4), 328. https://doi.org/10.3390/pharmaceutics12040328